72 related articles for article (PubMed ID: 10837621)
61. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
62. Man-made superantigens: Tumor-selective agents for T-cell-based therapy.
Dohlsten M; Kalland T; Gunnarsson P; Antonsson P; Molander A; Olsson J; d'Argy R; Ohlsson L; Soegaard M; Persson R; Brodin TN
Adv Drug Deliv Rev; 1998 Apr; 31(1-2):131-142. PubMed ID: 10837621
[TBL] [Abstract][Full Text] [Related]
63. Interplay between superantigens and immunoreceptors.
Petersson K; Forsberg G; Walse B
Scand J Immunol; 2004 Apr; 59(4):345-55. PubMed ID: 15049778
[TBL] [Abstract][Full Text] [Related]
64. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
65. Regulation of helper T cell responses to staphylococcal superantigens.
Cameron SB; Nawijn MC; Kum WW; Savelkoul HF; Chow AW
Eur Cytokine Netw; 2001; 12(2):210-22. PubMed ID: 11399508
[TBL] [Abstract][Full Text] [Related]
66. Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.
Hillman GG; Kallinteris NL; Lu X; Wang Y; Wright JL; Li Y; Wu S; Forman JD; Gulfo JV; Humphreys RE; Xu M
Cancer Treat Rev; 2004 May; 30(3):281-90. PubMed ID: 15059651
[TBL] [Abstract][Full Text] [Related]
67. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
[TBL] [Abstract][Full Text] [Related]
68.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
69.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
70.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
71.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
72.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]